Serum C-Reactive Protein-to-Body Mass Index Ratio Predicts Overall Survival in Patients With Resected Colorectal Cancer.
Lingxu HuangJungang LiuXiaoliang HuangChunyin WeiXianwei MoHuage ZhongYongsheng MengHao LaiLihua ZhangDingyu LiangHaizhou LiuWeizhong TangPublished in: Technology in cancer research & treatment (2021)
The C-reactive protein-to-body mass index ratio predicts the prognosis of patients with curatively resected colorectal cancer and is an independent risk factor for overall survival in patients with colorectal cancer.